|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection显示文摘 | REZK N L TIDWELL R R KASHUBA A D | 2003 | J Chromatogr B2003，791，12： | 1 |
| 2 | A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure显示文摘 | REZK N R BROWN K C KASHUBA A D M | 2006 | Journal of Chromatography B2006，844，2： | 1 |
| 3 | Optimizing amino-glycoside therpy for nosocomial pneumonia caused by gram- negative bacteria 显示文摘 | Kashuba A D Nafziger A N Drusano G L | 1999 | Antimicrob Agents Chemother1999，43，3： | 1 |
| 4 | The ultimate speed of magnetic switching in granular recording media显示文摘 | Tudosa I Stamm C Kashuba A B | 2004 | Nature2004，428，6985： | 1 |
| 5 | Quantification of intraindividual variability and the influ- ence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping 显示文摘 | Kashuba A D Nafziger A N Kearns G L | 1998 | Phar- macogenetics1998，8，5： | 1 |
| 6 | Not I linking/jumping clones of human chromosome 3: mapping of the TFRC,RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumors显示文摘 | KASHUBA V I GIZATULLIN R Z PROTOPOPOV A I | 1997 | FEBS Lett1997，419，： | 1 |
| 7 | Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection显示文摘 | REZK N L TIDWELL R R KASHUBA A D | 2003 | J Chromatogr B Analyt Technol Biomed Life Sci2003，791，12： | 1 |
| 8 | HIV prevention by oral preexposure prophylaxis 显示文摘 | Heneine W Kashuba A | 2012 | Cold Spring Harb Perspect Med2012，2，00： | 1 |
| 9 | Cytokine regulation of P glycoprotein显示文摘 | McRae MP Brouwer K Kashuba A | 2003 | Drug Metab Rev2003，35，1： | 1 |
| 10 | Anti- angiogenic and tumor-suppressive roles of candidate tumor- suppressor gene, Fibulin-2, in nasopharyngeal carcinoma 显示文摘 | LAW E W CHEUNG A K KASHUBA V I | 2012 | Oncogene2012，931，6： | 1 |
| 11 | Optimizing Aminoglycosid Therapy for Nosocomial pneumomia Caused by Gram Negative Bacteria显示文摘 | Kashuba A D M Nafziger A N Drusano G L | 1999 | Antimicr Agent Chemother1999，43，： | 1 |
| 12 | Relative frequencies 3f Alzheimer disease, Lewy body, vascular and frontotemporal flementia, and hippocampal sclerosis in the State of Florida Brain Bank显示文摘 | Barker WW Luis CA Kashuba A | 2002 | Alzheimer Dis Assoc Disord2002，16，： | 1 |
| 13 | Relative frequencies of Alzheimer disease,Lewy body,vascular and frontotemporal deanaentia,and hippocampal sclerosis in the State of Florida Brain Bank显示文摘 | Barker W W Luis C A Kashuba A et a1 | 2002 | Alzheimer Dis Assoc Disord2002，16，： | 1 |
| 14 | Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank 显示文摘 | Barker WW Luis CA Kashuba A | 2002 | Alzheimer Dis Assoc Disord2002，16，： | 1 |
| 15 | Notlsubtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes 显示文摘 | Li J Protopopov A Wang F Senchenko V Petushkov V Vorontsova O Petrenko L Zabarovska V Muravenko O Braga E Kisselev L Lerman M I Kashuba V Klein G Ernberg I Wahlestedt C Zabarovsky E R | 2002 | Proceedings of the National Academy of Sciences of the United States of America2002，99，10： | 1 |
| 16 | Narrative review:antiretro- viral therapy to prevent the sexual transmission of HIV-I显示文摘 | Cohen M S Gay C Kashuba A D | 2007 | Ann Intern Med2007，146，8： | 1 |
| 17 | 实时测井——MWD 结合地表测量完成钻井评价显示文摘随钻测量(MWD)测井服务已成为获取普查井和一些开采井的钻进与地层信息的一个重要新来源。测量地层、钻孔和钻柱的传感器安装在孔底装置内部,紧靠钻头上方几英尺.MWD 测量数据经计算机处理并储存在孔底测井仪中.简单的 MWD 测井系统必须等提钻后,才能把 MWD | A·Whittaker M·J·Kashuba 张明辉 | 1989 | 国外地质勘探技术1989，，6： | 0 |
| 18 | Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection显示文摘AIM: To assess whether reasons for hepatitis C virus(HCV) therapy non-initiation differentially affect racial and ethnic minorities with human immunodeficiency virus(HIV)/HCV co-infection.METHODS: Analysis included co-infected HCV treatment-na?ve patients in the University of North Carolina CFAR HIV Clinical Cohort(January 1, 2004 and December31, 2011). Medical records were abstracted to document non-modifiable medical(e.g., hepatic decompensation, advanced immunosuppression), potentially modifiable medical(e.g., substance abuse, severe depression, psychiatric illness), and non-medical(e.g., personal,social, and economic factors) reasons for non-initiation. Statistical differences in the prevalence of reasons for non-treatment between racial/ethnic groups were assessed using the two-tailed Fisher's exact test. Three separate regression models were fit for each reason category. Odds ratios and their 95%CIs(Wald's) were computed.RESULTS: One hundred and seventy-one patients with HIV/HCV co-infection within the cohort met study inclusion. The study sample was racially and ethnically diverse; most patients were African-American(74%), followed by Caucasian(19%), and Hispanic/other(7%). The median age was 46 years(interquartile range = 39-50) and most patients were male(74%). Among the 171 patients, reasons for non-treatment were common among all patients, regardless of race/ethnicity(50% with ≥ 1 non-modifiable medical reason, 66% with ≥1 potentially modifiable medical reason, and 66% with ≥ 1 non-medical reason). There were no significant differences by race/ethnicity. Compared to Caucasians, African-Americans did not have increased odds of nonmodifiable [adjusted odds ratio(a OR) = 1.47, 95%CI: 0.57-3.80], potentially modifiable(a OR = 0.72, 95%CI: 0.25-2.09) or non-medical(a OR = 0.90, 95%CI: 0.32-2.52) reasons for non-initiation.CONCLUSION: Race/ethnicity alone is not predictive of reasons for HCV therapy non-initiation. Targeted interventions are needed to improve access to therapy for all co-infected patients, including minorities. | Christine U Oramasionwu Angela DM Kashuba Sonia Napravnik David A Wohl Lu Mao Adaora A Adimora | 2016 | World Journal of Hepatology2016，8，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员